| Literature DB >> 21385415 |
Yongqiang Wang1, Zhonghui Kang, Honglei Gao, Yulong Gao, Liting Qin, Huan Lin, Fei Yu, Xiaole Qi, Xiaomei Wang.
Abstract
BACKGROUND: Infectious bursal disease (IBD) is a highly contagious immunosuppressive disease in young chickens caused by infectious bursal disease virus (IBDV). It causes huge economic losses to the poultry industry. The objective of this study is to develop a loop-mediated isothermal amplification (LAMP) method for the detection and discrimination of IBDV.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21385415 PMCID: PMC3063808 DOI: 10.1186/1743-422X-8-108
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Figure 1Primer design for RT-LAMP to detect IBDV based on the VP5 gene of Gx strain. (A). Genomic DNA sequence of vvIBDV Gx strain (GenBank Accession number: [AY444873]) VP5 gene from 181 to 417 nt in orientation 5' to 3'. Nucleotide sequences used for the primers are highlighted with grey background, and the arrows indicate the 5' to 3' direction of the primers. The open box shows the Tfi I restriction site exclusively located in non-vvIBDVs. (B). A table listing the names and sequences of all 6 primers.
Figure 2Specificity and sensitivity of RT-LAMP for the detection of IBDV. (A) Five related avian pathogens and vvIBDV Gx strain were subjected to RT-LAMP using the primers shown in Figure 1, and the RT-LAMP products were examined by both agarose gel electrophoresis (upper panel) and visually inspection for color changes (lower panel). Lanes M, DNA marker DL2000 (TaKaRa, China, with bands of 2000, 1000, 750, 500, 250 and 100 bp); 1, vvIBDV Gx strain; 2, avian influenza virus A/Chicken/Shandong/6/96 (H9N2) strain; 3, Newcastle disease virus La sota strain; 4, infectious bronchitis virus F strain; 5, Marek's disease virus CV1988 strain; 6, chicken anemia virus M9905 strain; 7, DEPC-treated water. (B) RNA standards in vitro transcribed and serially diluted were subjected to RT-LAMP and the RT-LAMP products were examined by both agarose gel electrophoresis (upper panel) and visually inspection for color changes (lower panel). Lanes M, DNA marker DL2000 (TaKaRa, China); 1-6, 2.8 × 105, 2.8 × 104, 2.8 × 103, 2.8 × 102, 2.8 × 101 and 2.8 × 10° copies of RNA, respectively; 7, DEPC-treated water.
Nucleotide sequences of vvIBDVs at the TfiI site.
| Strains/isolates | Accession number | Geographic origin | Nucleotides at the restriction site |
|---|---|---|---|
| Gx | AY444873 | China | G T T T CNote |
| Harbin-1 | EF517528 | China | . . . . . |
| SH95 | AY134874 | China | . . . . . |
| GZ/96 | AY598356 | China | . . . . . |
| HK46 | AF092943 | Hongkong | . . . . . |
| Chinju | AF508176 | Korea | . . . . . |
| SH/92 | AF533670 | Korea | . . . . . |
| OKYM | D49706 | Japan | . . . . . |
| SDH1 | AY323952 | Iran | . . . . . |
| BD 3/99 | AF362776 | Bangladesh | . . . . . |
| UPM97/61 | AF247006 | Malaysia | . . . . . |
| UPM94/273 | AF527039 | Malaysia | . . . . . |
| UPM92-04 | AF262030 | Malaysia | . . . . . |
| B00/73 | AY520909 | Malaysia | . . . . . |
| B00/81 | AY520910 | Malaysia | . . . . . |
| 94230 | AY520911 | Malaysia | . . . . . |
| Tasik94 | AF322444 | Indonesia | . . . . . |
| T09 | AY099456 | Nigeria | . . . . . |
| PO7 | AY665672 | Tunisia | . . . . . |
| ks | DQ927042 | Israel | . . . . . |
| UK661 | AJ318896 | U.K. | . C . . . |
| 02015.1 | AJ879932 | France | . . . . . |
| D6948 | AF240686 | Netherlands | . . . . . |
| Ipumirim-BR | AY769978 | Brazil | . . . . . |
| SM-BR | AY780418 | Brazil | . . . . . |
| MG7 | DQ286035 | Brazil | . . . . . |
NoteThe TfiI site was 5'GAWTC3' W = A or T. Dark dot indicated residue which was identical to the vvIBDV Gx. There was no TfiI site in vvIBDVs.
Nucleotide sequences of non-vvIBDVs at the TfiI stie.
| Strains/isolates | Accession number | Geographic origin | Phenotype | Nucleotides in the restriction site |
|---|---|---|---|---|
| Gt | DQ403248 | China | Attenuated | G A T T CNote |
| HZ2 | AF321054 | China | Attenuated | . . . . . |
| JD1 | AF321055 | China | Attenuated | . . . . . |
| CJ801bkf | AF006694 | China | Attenuated | . . . . . |
| GZ29112 | AF051837 | China | Attenuated | . . . . . |
| NB | AY319768 | China | Attenuated | . . . . . |
| CEF94 | AF194428 | Netherlands | Attenuated | . . . . . |
| D78 | AF499929 | Luxembourg | Attenuated | . . . . . |
| CT | AJ310185 | France | Attenuated | . . . . . |
| Cu-1 M | AF362771 | Germany | Attenuated | . . . . . |
| P2 | X84034 | Germany | Attenuated | . . . . . |
| Edgar T | AY462026 | USA | Attenuated | . . . . . |
| 002-73 | X03993 | Australia | Classical | . . . . . |
| CU-1 | X16107 | Germany | Classical | . . . . . |
| CS-2-35 | EF418033 | USA | Classical | . . . . . |
| GA-1 | EF418034 | USA | Classical | . . . . . |
| H-30 | EF418035 | USA | Classical | . . . . . |
| P3009 | AF109154 | Taiwan | Classical | . . . . . |
| A-BH83 | DQ187988 | Brazil | Classical | . . . . . |
| STC | D00499 | USA | Classical | . . . . . |
| Cu1 | D00867 | Germany | Classical | . . . . . |
| PBG-98 | D00868 | U. K. | Classical | . . . . . |
| 52/70 | D00869 | U. K. | Classical | . . . . . |
| IM | AY029166 | USA | Classical | . . . . . |
| Cu-1 wt | AF362747 | Germany | Classical | . . . . . |
| Lukert | AY918948 | USA | Classical | . . . . . |
| Edgar C | AY918950 | USA | Classical | . . . . . |
| GLS | AY368653 | USA | Variant | . . . . . |
| varient E | AF133904 | USA | Variant | . . . . . |
| 23/82 | AF362773 | U. K. | Serotype II; | . . . . . |
| OH | M66722 | Canada | Serotype II; | . . . . . |
NoteThe TfiI site was 5'GAWTC3' W = A or T. Dark dot indicated residue which was identical to the attenuated Gt. There was a TfiI site in non-vvIBDVs.
Figure 3Different Tfi I restriction patterns of RT-LAMP products of vvIBDV Gx and attenuated Gt strains. RT-LAMP products were digested by Tfi I and subjected to a 2% agarose gel. After ethidium bromide staining, DNA band patterns were photographed under a UV transilluminator. Lanes M, DNA marker DL2000 (TaKaRa, China, with 2000, 1000, 750, 500, 250 and 100 bp bands); 1, RT-LAMP product of Gx digested by Tfi I; 2, RT-LAMP product of Gt digested by Tfi I.
Detection rates of clinical specimens by RT-PCR, real-time RT-PCR and RT-LAMP
| Source (NO. of specimens) | RT-PCR | real-time RT-PCR | RT-LAMP | |||
|---|---|---|---|---|---|---|
| Positive | Negative | Positive | Negative | Positive | Negative | |
| Hei Longjiang (18) | 17 | 1 | 18 | 0 | 18 | 0 |
| Shan Dong (9) | 6 | 3 | 8 | 1 | 9 | 0 |
| Ji Lin (6) | 6 | 0 | 6 | 0 | 6 | 0 |
| Jiang Su (2) | 1 | 1 | 2 | 0 | 1 | 1 |
| Jiang Xi (1) | 0 | 1 | 1 | 0 | 1 | 0 |
| Shang Hai (1) | 1 | 0 | 1 | 0 | 1 | 0 |
| Guang Xi (1) | 1 | 0 | 1 | 0 | 1 | 0 |
| Yun Nan (1) | 1 | 0 | 1 | 0 | 1 | 0 |
| Hu Nan (1) | 1 | 0 | 1 | 0 | 1 | 0 |
| Hu Bei (1) | 1 | 0 | 1 | 0 | 1 | 0 |
| Fu Jian (1) | 1 | 0 | 1 | 0 | 1 | 0 |
| -a (6) | 2 | 4 | 5 | 1 | 5 | 1 |
| Total (48) | 38 | 10 | 46 | 2 | 46 | 2 |
| Percent (%) | 79.2 | 20.8 | 95.8 | 4.2 | 95.8 | 4.2 |
aindicates unknown background information on the specimens.